ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2021
Correction to: CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway.
Elisabet Ampudia-Mesias et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.